UnitedHealth Group met its earnings expectations for Q1 2014, demonstrating solid revenue growth and strong cash flow. However, significant headwinds from ACA implementation, increased costs from hepatitis C therapies, and pricing pressures in key markets like New York could weigh on investor sentiment in the short term.

[-1]